Abstract:Naeti Suksomboon, 1 Nalinee Poolsup, 2 Wei Lin 1 1 Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2 Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand Background: Kiwifruit seems to have beneficial effect on metabolic health because it contains abundant phytochemicals and antioxidants. This study aimed to assess the effect of kiwifruit on metabolic health in participants with cardiovascular risk factors. Methods: Literature was searched from PubMed, CENTRAL, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Scopus, Proquest, Latin American and Caribbean Health Sciences Literature, International Clinical Trials Registry Platform, Australia New Zealand Clinical Trials Registry, https://clinicaltrials.gov/ , China National Knowledge Infrastructure, Wanfang Standards Database, European Association for the Study of Diabetes, and American Diabetes Association conferences up to August 2018. Citing references were manually searched. Randomized controlled trials were selected if they evaluated the effect of kiwifruit in patients with cardiovascular risk factors and reported SBP, DBP, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glycated hemoglobin (A1C), fasting plasma glucose (FPG), homeostasis model assessment of insulin resistance (HOMA-IR), 2-hour postprandial glucose, or body weight (BW). Data extraction and study quality assessment were performed independently by two investigators. Any inconsistencies were resolved by a third investigator. Treatment effect was estimated with mean difference (MD). Effect estimates were pooled using inverse-variance weighted method. Heterogeneity was assessed by the I 2 and Q statistic. Results: Five randomized controlled trials involving 489 participants met the inclusion criteria. These included hypercholesterolemia, hypertension, type 2 diabetes mellitus, and male smokers. There was no effect of kiwifruit on SBP (MD, –1.72 mmHg; 95% CI: –4.27 to 0.84); DBP (MD, –2.35 mmHg; 95% CI: –5.10 to 0.41); TC (MD, –0.14 mmol/L; 95% CI: –0.71 to 0.43); TG (MD, –0.23 mmol/L; 95% CI: –0.66 to 0.20); LDL-C (MD, –0.41 mmol/L; 95% CI: –0.99 to 0.18); HDL-C (MD, 0.15 mmol/L; 95% CI: –0.18 to 0.48); FPG (MD, –0.08 mmol/L; 95% CI: –0.37 to 0.21); HOMA-IR (MD, –0.29; 95% CI: –0.61 to 0.02), and BW (MD, –1.08 kg; 95% CI: –4.22 to 2.05). Conclusion: This meta-analysis suggested no effect of kiwifruit on metabolic health in patients with cardiovascular risk factors, although there seemed to be a trend of improvement after kiwifruit intervention. Keywords: Actinidia , metabolic diseases, lipid, cholesterol, blood glucose, blood pressure

Kiwifruit (Actinidia deliciosa) aqueous extract improves hyperglycemia, testicular inflammation, apoptosis, and tissue structure induced by Streptozotocin via oxidative stress inhibition

Actinidia deliciosa Extract as a Promising Supplemental Agent for Hepatic and Renal Complication-Associated Type 2 Diabetes (In Vivo and In Silico-Based Studies)

Insoluble and Soluble Dietary Fibers from Kiwifruit (Actinidia deliciosa) Modify Gut Microbiota to Alleviate High-Fat Diet and Streptozotocin-Induced TYPE 2 Diabetes in Rats

Insoluble and Soluble Dietary Fibers from Kiwifruit (<i>Actinidia deliciosa</i>) Modify Gut Microbiota to Alleviate High-Fat Diet and Streptozotocin-Induced TYPE 2 Diabetes in Rats

Immune boosting and Anti-oxidant activities of kiwifruit extract on hydrogen peroxide induced toxicity in Rats . 1

Kiwifruit Peel Extract Improves the Alterations in Lipid Metabolism in High-fat Diet-fed Model Rats

The Effect of Kiwifruit Therapeutics in the Treatment of Diabetic Foot Ulcer

Polyphenols and Pectin Enriched Golden Kiwifruit(actinidia Chinensis)alleviates High Fructose-Induced Glucolipid Disorders and Hepatic Oxidative Damage in Rats:In Association with Improvement of Fatty Acids Metabolism

Anti-hyperglycemic activity of kiwifruit leaf (Actinidia deliciosa) in mice

Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis

Total flavonoids of Epimedium ameliorates testicular damage in streptozotocin‐induced diabetic rats by suppressing inflammation and oxidative stress

Physalis pubescens L. alleviates testicular disruptions associated with streptozotocin-induced diabetes in male Wistar rats, Rattus norvegicus

Evaluation The Ameliorative Effect of Alcoholic Extracts of Citrullus colocynthis and Phyllanthus Emblica Fruits on Streptozotocin-Induced Diabetes in Male Rats

Zingiber officinale preserves testicular structure and the expression of androgen receptors and proliferating cell nuclear antigen in diabetic rats

Edible wild plants, chicory and purslane, alleviated diabetic testicular dysfunction, and insulin resistance via suppression 8OHdg and oxidative stress in rats

Icariin improves testicular dysfunction via enhancing proliferation and inhibiting mitochondria-dependent apoptosis pathway in high-fat diet and streptozotocin-induced diabetic rats

The protective effects of icariin against testicular dysfunction in type 1 diabetic mice Via AMPK-mediated Nrf2 activation and NF-κB p65 inhibition

Development of a Polyphenol-Enriched Whole Kiwifruit Dietary Supplement and Its Potential in Ameliorating Hyperlipidemia

Consumption of Two Whole Kiwifruit (actinide Chinensis) Per Day Improves Lipid Homeostasis, Fatty Acid Metabolism and Gut Microbiota in Healthy Rats.

Erythritol attenuates testicular dysfunction in diabetic rat via suppression of oxidative stress, inflammation and apoptosis

Medicinal, Nutritional and Health Benefits, Pharmacological Properties of KIWI – A Review